Scope
From 1 May 2026, State Council Order 818 governs biomedical-new-technology clinical research and clinical translation. Clinical research requires prior nonclinical evidence, academic and ethics approval, and NHC filing within 5 working days after those approvals. Drug/device clinical trials remain under their separate regulatory regimes; use the NHC/NMPA boundary guidance rather than a legacy universal dual-filing model.
